M&A evaluation in pharmaceutical industry: empirical findings

Marini, Filippo (A.A. 2022/2023) M&A evaluation in pharmaceutical industry: empirical findings. Tesi di Laurea in Equity markets and alternative investments, Luiss Guido Carli, relatore Marco Morelli, pp. 82. [Master's Degree Thesis]

Full text for this thesis not available from the repository.

Abstract/Index

Pharma industry. Overview of pharma industry. Historical development. Main players in the global market. The impact of Covid-19 on pharma industry. The future of pharma industry. Mergers in pharma industry. Why M&A? Pharmaceuticals suffer from the urge to merge. Impact of M&A on corporate growth process. Outsourcing through acquisition. Bid strategies. M&A’s strategies evolution. Drivers of M&A activity in the pharma sector. Abnormal returns methodology to study the impact of mergers on shareholder value. Event study methodology. Research question. Data collection and description. Methodology. Empirical results. Short term analysis across all sample. Cross border vs domestic operations. Companies with multiple M&As versus one. Pandemic impact on pharma mergers.

References

Bibliografia: pp. 80-81.

Thesis Type: Master's Degree Thesis
Institution: Luiss Guido Carli
Degree Program: Master's Degree Programs > Master's Degree Program in Economics and Finance (LM-56)
Chair: Equity markets and alternative investments
Thesis Supervisor: Morelli, Marco
Thesis Co-Supervisor: Venosi, Edoardo Maria
Academic Year: 2022/2023
Session: Autumn
Deposited by: Alessandro Perfetti
Date Deposited: 13 Jun 2024 10:38
Last Modified: 13 Jun 2024 10:38
URI: https://tesi.luiss.it/id/eprint/38942

Downloads

Downloads per month over past year

Repository Staff Only

View Item View Item